213 related articles for article (PubMed ID: 34962708)
21. Comparison Study of Laparoscopic Sentinel Lymph Node Mapping in Endometrial Carcinoma Using Carbon Nanoparticles and Lymphatic Pathway Verification.
Zuo J; Wu LY; Cheng M; Bai P; Lei CZ; Li N; Zhang GY; Zhao D; Li B
J Minim Invasive Gynecol; 2019; 26(6):1125-1132. PubMed ID: 30445188
[TBL] [Abstract][Full Text] [Related]
22. Sentinel lymph node mapping with staging lymphadenectomy for patients with endometrial cancer increases the detection of metastasis.
Holloway RW; Gupta S; Stavitzski NM; Zhu X; Takimoto EL; Gubbi A; Bigsby GE; Brudie LA; Kendrick JE; Ahmad S
Gynecol Oncol; 2016 May; 141(2):206-210. PubMed ID: 26905211
[TBL] [Abstract][Full Text] [Related]
23. Robotic sentinel lymph node (SLN) mapping in endometrial cancer: SLN symmetry and implications of mapping failure.
Stephens AJ; Kennard JA; Fitzsimmons CK; Manyam M; Kendrick JE; Singh C; McKenzie ND; Ahmad S; Holloway RW
Int J Gynecol Cancer; 2020 Mar; 30(3):305-310. PubMed ID: 31857439
[TBL] [Abstract][Full Text] [Related]
24. Patient-reported outcomes after surgery for endometrial carcinoma: Prevalence of lower-extremity lymphedema after sentinel lymph node mapping versus lymphadenectomy.
Leitao MM; Zhou QC; Gomez-Hidalgo NR; Iasonos A; Baser R; Mezzancello M; Chang K; Ward J; Chi DS; Long Roche K; Sonoda Y; Brown CL; Mueller JJ; Gardner GJ; Jewell EL; Broach V; Zivanovic O; Dowdy SC; Mariani A; Abu-Rustum NR
Gynecol Oncol; 2020 Jan; 156(1):147-153. PubMed ID: 31780238
[TBL] [Abstract][Full Text] [Related]
25. "Long-term outcome in endometrial cancer patients after robot-assisted laparoscopic surgery with sentinel lymph node mapping".
Jebens Nordskar N; Hagen B; V Vesterfjell E; Salvesen Ø; Aune G
Eur J Obstet Gynecol Reprod Biol; 2022 Apr; 271():77-82. PubMed ID: 35151960
[TBL] [Abstract][Full Text] [Related]
26. Sentinel lymph node mapping with indocyanine green in cervical cancer patients undergoing open radical hysterectomy: a single-institution series.
Bizzarri N; Luigi PA; Ferrandina G; Zannoni GF; Carbone MV; Fedele C; Teodorico E; Gallotta V; Gueli Alletti S; Chiantera V; Fagotti A; Scambia G; Fanfani F
J Cancer Res Clin Oncol; 2021 Mar; 147(3):649-659. PubMed ID: 33000339
[TBL] [Abstract][Full Text] [Related]
27. Indocyanine green fluorescence imaging of lymph nodes during robotic-assisted laparoscopic operation for endometrial cancer. A prospective validation study using a sentinel lymph node surgical algorithm.
Hagen B; Valla M; Aune G; Ravlo M; Abusland AB; Araya E; Sundset M; Tingulstad S
Gynecol Oncol; 2016 Dec; 143(3):479-483. PubMed ID: 27776838
[TBL] [Abstract][Full Text] [Related]
28. The impact on survival of two different staging strategies in apparent early stage endometrial cancer comparing sentinel lymph nodes mapping algorithm and selective lymphadenectomy: An Italian retrospective analysis of two reference centers.
Buda A; Di Martino G; Restaino S; De Ponti E; Monterossi G; Giuliani D; Ercoli A; Dell'Orto F; Dinoi G; Grassi T; Scambia G; Fanfani F
Gynecol Oncol; 2017 Dec; 147(3):528-534. PubMed ID: 29032824
[TBL] [Abstract][Full Text] [Related]
29. Lymph node evaluation in high-risk early stage endometrial cancer: A multi-institutional retrospective analysis comparing the sentinel lymph node (SLN) algorithm and SLN with selective lymphadenectomy.
Buda A; Gasparri ML; Puppo A; Mereu L; De Ponti E; Di Martino G; Novelli A; Tateo S; Muller M; Landoni F; Papadia A
Gynecol Oncol; 2018 Aug; 150(2):261-266. PubMed ID: 29887483
[TBL] [Abstract][Full Text] [Related]
30. Comparison of oncological outcomes between sentinel lymph node biopsy and complete lymphadenectomy for endometrial cancer.
Makroum AA; Lee YJ; Lee JY; Nam EJ; Kim S; Kim SW; Kim YT
J Obstet Gynaecol Res; 2023 Aug; 49(8):2118-2125. PubMed ID: 37286510
[TBL] [Abstract][Full Text] [Related]
31. Uptake and Outcomes of Sentinel Lymph Node Mapping in Women With Atypical Endometrial Hyperplasia.
Dioun S; Chen L; Melamed A; Gockley A; St Clair CM; Hou JY; Tergas AI; Khoury-Collado F; Hur C; Hershman DL; Wright JD
Obstet Gynecol; 2021 May; 137(5):924-934. PubMed ID: 33831939
[TBL] [Abstract][Full Text] [Related]
32. Lymphatic Mapping and Sentinel Node Biopsy in High-Grade Uterine Cancers.
How JA; Frumovitz M; Stewart KI; Soliman PT
Curr Oncol Rep; 2022 Nov; 24(11):1521-1529. PubMed ID: 35781863
[TBL] [Abstract][Full Text] [Related]
33. Sentinel lymph node intraoperative analysis in endometrial cancer.
Bellaminutti S; Bonollo M; Gasparri ML; Clivio L; Migliora P; Mazzucchelli L; Papadia A
J Cancer Res Clin Oncol; 2020 Dec; 146(12):3199-3205. PubMed ID: 32815026
[TBL] [Abstract][Full Text] [Related]
34. Sentinel lymph node biopsy in early stage endometrial cancer: a Turkish gynecologic oncology group study (TRSGO-SLN-001).
Taşkın S; Altin D; Vatansever D; Tokgozoglu N; Karabük E; Turan H; Takmaz Ö; Kahramanoglu I; Naki MM; Güngör M; Köse F; Ortac F; Arvas M; Ayhan A; Taskiran C
Int J Gynecol Cancer; 2020 Mar; 30(3):299-304. PubMed ID: 31857440
[TBL] [Abstract][Full Text] [Related]
35. Sentinel Lymph Node Mapping in Endometrial Cancer: An Update.
Khoury-Collado F; St Clair C; Abu-Rustum NR
Oncologist; 2016 Apr; 21(4):461-6. PubMed ID: 26961924
[TBL] [Abstract][Full Text] [Related]
36. Trends in Sentinel Lymph Node Mapping and Adjuvant Therapy in Endometrial Carcinoma.
Gómez-Hidalgo NR; Chen L; Hou JY; Tergas AI; St Clair CM; Ananth CV; Hershman DL; Wright JD
Cancer Invest; 2018 Mar; 36(3):190-198. PubMed ID: 29565689
[TBL] [Abstract][Full Text] [Related]
37. Success Rates of Sentinel Lymph Node Mapping for Endometrial Cancer in Patients with Body Mass Index < 45 Compared with Body Mass Index ≥ 45.
Fennimore NJ; Fitch K; Kiff J; Nguyen CG; Garg B; Munro EG; Bruegl AS
J Minim Invasive Gynecol; 2023 Sep; 30(9):735-741. PubMed ID: 37142090
[TBL] [Abstract][Full Text] [Related]
38. The Role of Sentinel Lymph Node Mapping in High-grade Endometrial Cancer.
Yu R; Matthews BJ; Beavis AL
Curr Treat Options Oncol; 2022 Oct; 23(10):1339-1352. PubMed ID: 35980519
[TBL] [Abstract][Full Text] [Related]
39. Sentinel Node Mapping Using Indocyanine Green and Near-infrared Fluorescence Imaging Technology for Uterine Malignancies: Preliminary Experience With the Da Vinci Xi System.
Siesto G; Romano F; Fiamengo B; Vitobello D
J Minim Invasive Gynecol; 2016; 23(4):470-1. PubMed ID: 26767824
[TBL] [Abstract][Full Text] [Related]
40. Usefulness and potential pitfalls of pre-operative PET-CT in patients with endometrial cancer undergoing one- and two-step sentinel lymph node mapping: Do negative findings on PET-CT negativity really indicate node negativity?
Kim YN; Lee D; Cha J; Kang WJ; Lee YJ; Lee JY; Nam EJ; Kim S; Kim YT; Kim SW
Gynecol Oncol; 2022 Sep; 166(3):438-443. PubMed ID: 35907682
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
